Delivery Order SPE2DR25D1041-SPE2DR26FHR5B
- Not listed
- This delivery order, awarded on September 22, 2025, represents a $3,627.02 firm fixed-price purchase of Vemlidy 25 mg tablets (30-count units) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for supplying medical and pharmaceutical products to military and veteran healthcare systems. This award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,018.04 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.15 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count unit dose packaging) on December 23, 2025, with completion scheduled for December 24, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) at a ceiling value of $3,346.62. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by October 21, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.33 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-tablet units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $6,832.55 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count unit) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $8,252.06. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its place of performance in the same location. The award represents...
- The Defense Logistics Agency awarded a delivery order valued at $4,822.46 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a delivery order valued at $4,932.38 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 9, 2026, with completion scheduled for January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- SPE2DR25D1041Indefinite Delivery Contract
- SPE2DR25D1041-SPE2DR26FHR5BDelivery Order
This delivery order, awarded on February 3, 2026, represents a $20,047.15 firm fixed-price purchase of Vemlidy 25 mg tablets (30-count unit dose) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is funded by the Defense Logistics Agency (DLA), a Department of Defense logistics organization responsible for supplying pharmaceuticals and medical materiel to military healthcare systems. This award was issued on a non-set-aside basis, indicating full and open competition. The delivery order is expected to be completed by February 4, 2026, reflecting the time-sensitive nature of pharmaceutical procurement for federal medical supply needs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., issued this delivery order under its existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The award demonstrates AmerisourceBergen's ongoing role as a critical vendor within the federal medical supply chain, leveraging its established contract vehicle to fulfill specific pharmaceutical requirements for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 2/2/26 |